bladder carcinoma

Related by string. * Bladder : Tengion Neo Bladder Augment . liver spleen gall bladder . gall bladder removed . Spleen gall bladder . gall bladder / carcinomas . Carcinoma . Carcinomas : Renal Cell Carcinoma RCC . superficial basal cell carcinoma . transitional cell carcinoma . basal cell carcinoma BCC . squamous cell carcinoma SCC * superficial bladder carcinoma *

Related by context. Frequent words. (Click for all words.) 71 pancreatic adenocarcinoma 69 breast carcinoma 69 colorectal carcinoma 68 MGUS 66 PCa 66 HSCT 66 Lenalidomide 66 cholangiocarcinoma 65 gastrointestinal stromal tumors GIST 65 μmol L 65 malignant pleural mesothelioma 65 cervical intraepithelial neoplasia 65 neoplasm 65 HNSCC 65 metastatic renal cell carcinoma 64 Natalizumab 64 biochemical recurrence 64 androgen deprivation 64 Idiopathic Pulmonary Fibrosis 64 H pylori 64 KRAS mutations 64 carcinoid tumors 64 mRCC 64 HER2 positive metastatic breast 64 lymph node dissection 64 multiple myeloma MM 64 leukemia ALL 64 immunostaining 64 superficial bladder cancer 63 gastrointestinal stromal tumors 63 lymph node metastasis 63 TACE 63 neoadjuvant therapy 63 neoplastic 63 immunohistochemical 63 % CI #.#-#.# [003] 63 resectable 63 posttreatment 63 secondary hyperparathyroidism 63 neoadjuvant 63 PDGFR 63 hepatocellular carcinoma HCC 63 glioblastoma multiforme GBM 63 pheochromocytoma 62 metastatic lesions 62 Trastuzumab 62 T2DM 62 cystectomy 62 mCRC patients 62 chemoradiotherapy 62 hematologic toxicity 62 Asymptomatic 62 murine model 62 prognostic factor 62 histologically 62 locoregional 62 tigecycline 62 Malignancies 62 castration resistant prostate cancer 62 bone metastasis 62 neoplasia 62 neoadjuvant chemotherapy 62 CD# + [001] 62 tumor lysis syndrome 62 epithelial ovarian cancer 62 HBsAg 62 metastatic castration resistant 62 SHPT 62 rhGH 62 multivariate analyzes 62 geographic atrophy 62 acute myelogenous leukemia AML 61 histopathological 61 immunoreactivity 61 paroxysmal nocturnal hemoglobinuria 61 Dasatinib 61 Bortezomib 61 Combination therapy 61 hepatocellular carcinoma 61 FLT3 61 metastatic RCC 61 serum albumin 61 medullary thyroid cancer 61 carcinoid 61 PsA 61 Carcinoma 61 lymphopenia 61 latent tuberculosis infection 61 Renal Cell Carcinoma 61 pericardial effusion 61 statistically significant p = 61 leukemia CLL 61 refractory chronic lymphocytic 61 decitabine 61 thyroid nodules 61 prognostic marker 61 Ischemic 61 nephrotoxicity 61 neoplasms 61 heavily pretreated 61 lanthanum carbonate

Back to home page